Only one prospective study evaluated the impact of liraglutide versus placebo in 30 people with obesity and COPD at different times on lung function tests, 6 min walk test, and responses to a questionnaire on the clinical impact of COPD (COPD assessment testCAT score)
Even the cardiovascular concerns with GLP-1 agonists are simpler to manage than seizure risk in this population
These functions may help protect cells needed for brain health, which may benefit people with neurodegenerative conditions such as Alzheimers and Parkinsons diseases
Reducing the release of glucose from the liver, which can help to lower blood sugar levels
However, published research has raised an important clinicalquestion: how much of the weight being lost is actually fat, and how much islean tissue
Sometimes, the biggest shift comes from simply becoming aware of how much youre eatingwithout restriction, guilt, or obsessing over numbers